Circulating maternal concentrations of hormonally active vitamin D [calcitriol, 1,25(OH)2D] rise early in the first trimester, doubling by the end of the third trimester. The early rise in calcitriol is believed to be necessary for enabling the immunological adaptation by the mother required for the maintenance of a normal pregnancy. This immunological adaptation is characterized by downregulation of the T helper type 1 (Th1) cytokine responses and a shift towards domination by the Th2 type responses. Attenuation of the Th1-mediated immune response is one of the influences of calcitriol on regulatory T cell activity and dendritic cell maturation. There is accumulating evidence that vitamin D supplementation may be able to prevent the immune maladaptation and loss of tolerance that occur in preeclampsia, with evidence for an association obtained from various types of observational studies and clinical trials. There is also evidence from observational studies for potential long-term programming effects of vitamin D supplementation on immunological diseases (such as type 1 diabetes and allergic diseases), with evidence supporting the role of active vitamin D as a potent immunomodulator. This paper highlights the complex effects of active vitamin D on immunomodulation with long-term implications for the risk of immunological diseases. It is suggested that it is essential to avoid vitamin D deficiency during pregnancy, and while accumulating evidence suggests important benefits of further increases in the intake, further research is required to fully establish the influence of high dosages.

Keywords:
Vitamin D, Deficiency, Supplementation, Pregnancy, Programming, Immune function
1.
Calvo MS, Whiting SJ, Barton CN: Vitamin D intake: a global perspective of current status. J Nutr 2005;135:310–316.
2.
Tylavsky FA, Cheng S, Lyytikainen A, Viljakainen H, Lamberg-Allardt C: Strategies to improve vitamin D status in Northern European children: exploring the merits of vitamin D fortification and supplementation. J Nutr 2006;136:1130–1134.
3.
Hyppönen E, Boucher BJ: Avoidance of vitamin D deficiency in pregnancy in the United Kingdom: the case for a unified approach in national policy. Br J Nutr 2010;104:309–314.
4.
Hyppönen E, Power C: Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85:860–868.
5.
Doets EL, de Wit LS, Dhonukshe-Rutten RA, Cavelaars AE, Raats MM, Timotijevic L, Brzozowska A, Wijnhoven TM, Pavlovic M, Totland TH, Andersen LF, Ruprich J, Pijls LT, Ashwell M, Lambert JP, van tV, de Groot LC: Current micronutrient recommendations in Europe: towards understanding their differences and similarities. Eur J Nutr 2008;47(suppl 1):17–40.
6.
Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds): Dietary Reference Intakes for Calcium and Vitamin D. Washingon, IOM, 2010.
7.
Hollis BW: Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 2007;22(suppl 2):V39–V44.
8.
Bivins R: ‘The English disease’ or ‘Asian rickets’? Medical responses to postcolonial immigration. Bull Hist Med 2007;81:533–568.
9.
Shenoy SD, Swift P, Cody D, Iqbal J: Maternal vitamin D deficiency, refractory neonatal hypocalcaemia, and nutritional rickets. Arch Dis Child 2005;90:437–438.
10.
Cockburn F, Belton NR, Purvis RJ, Giles MM, Brown JK, Turner TL, Wilkinson EM, Forfar JO, Barrie WJ, McKay GS, Pocock SJ: Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J 1980;281:11–14.
11.
Maiya S, Sullivan I, Allgrove J, Archer N, Tulloh R, Daubeney P, Malone M, Mok Q, Yates R, Brain C, Burch M: Hypocalcaemia and vitamin D deficiency: an important, but preventable cause of life threatening infant heart failure. Heart 2008;94:581–584.
12.
Hypocalcemic seizures in breastfed infants with rickets secondary to severe maternal vitamin D deficiency. Pak J Biol Sci 2010;13:437–442.
13.
Derbyshire E, Davies GJ, Costarelli V, Dettmar PW: Habitual micronutrient intake during and after pregnancy in Caucasian Londoners. Matern Child Nutr 2009;5:1–9.
14.
Evans KN, Bulmer JN, Kilby MD, Hewison M: Vitamin D and placental-decidual function. J Soc Gynecol Investig 2004;11:263–271.
15.
Raghupathy R: Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001;13:219–227.
16.
Spilianakis CG, Lee GR, Flavell RA: Twisting the Th1/Th2 immune response via the retinoid X receptor: lessons from a genetic approach. Eur J Immunol 2005;35:3400–3404.
17.
Hayes CE, Nashold FE, Spach KM, Pedersen LB: The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49:277–300.
18.
Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005;365:785–799.
19.
Saito S, Sakai M: Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003;59:161–173.
20.
Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM: Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007;92:3517–3522.
21.
Haugen M, Brantsaeter AL, Trogstad L, Alexander J, Roth C, Magnus P, Meltzer HM: Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009;20:720–726.
22.
Hyppönen E: Vitamin D for the prevention of pre-eclampsia? A hypothesis. Nutrition Reviews 2005;63:225–232.
23.
Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL: Vitamin D supplementation during pregnancy: double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011, DOI: 10.1002/jbmr.463.
24.
Spencer SJ, Galic MA, Pittman QJ: Neonatal programming of innate immune function. Am J Physiol Endocrinol Metab 2011;300:E11–E18.
25.
Arens R, Schoenberger SP: Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 2010;235:190–205.
26.
Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM: Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500–1503.
27.
Hyppönen E, Hartikainen AL, Sovio U, Jarvelin MR, Pouta A: Does vitamin D supplementation in infancy reduce the risk of pre-eclampsia? Eur J Clin Nutr 2007;61:1136–1139.
28.
Hyppönen E, Sovio U, Wjst M, Patel S, Pekkanen J, Hartikainen AL, Järvelin MR: Infant vitamin D supplementation and allergic conditions in adulthood – Northern Finland Birth Cohort 1966. Ann NY Acad Sci 2004;1037:84–95.
29.
Gale CR, Robinson SM, Harvey NC, Javaid MK, Jiang B, Martyn CN, Godfrey KM, Cooper C: Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 2008;62:68–77.
30.
Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, Kleinman K, Gillman MW: Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 2007;85:788–795.
31.
Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, Martindale S, Helms PJ, Seaton A, Weiss ST: Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 2007;85:853–859.
32.
Matheu V, Back O, Mondoc E, Issazadeh-Navikas S: Dual effects of vitamin D- induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol 2003;112:585–592.
33.
Hyppönen E, Berry D, Wjst M, Power C: Serum 25-hydroxyvitamin D and IgE – a significant but nonlinear relationship. Allergy 2009;64:613–620.
34.
Castellani ML, Shaik-Dasthagirisaheb YB, Tripodi D, Anogeianaki A, Felaco P, Toniato E, De Lutiis MA, Fulcheri M, Tete S, Galzio R, Salini V, Caraffa A, Antinolfi P, Frydas I, Sabatino G, Kempuraj D: Interrelationship between vitamins and cytokines in immunity. J Biol Regul Homeost Agents 2010;24:385–390.
35.
Robinson CJ, Wagner CL, Hollis BW, Baatz JE, Johnson DD: Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol 2011;204:556.e1–556.e4.
36.
Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ: Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG 2010;117:1593–1598.
37.
Leffelaar ER, Vrijkotte TG, van Eijsden M: Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multi-ethnic Amsterdam Born Children and their Development cohort. Br J Nutr 2010;104:108–117.
38.
Krishnaveni GV, Veena SR, Winder NR, Hill JC, Noonan K, Boucher BJ, Karat SC, Fall CH: Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study. Am J Clin Nutr 2011;93:628–635.
39.
Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, Godfrey KM, Cooper C: Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006;367:36–43.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.